|
RELATED PARTY TRANSACTIONS (Detail) (USD $)
|
12 Months Ended | 12 Months Ended | 12 Months Ended | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2012
|
Jun. 30, 2011
|
Jun. 30, 2010
|
Jun. 30, 2010
current Good Manufacturing Practices [Member]
FhCMB [Member]
|
Jun. 30, 2012
Gene Expression And Protein Production [Member]
FhCMB [Member]
|
Jun. 30, 2011
Gene Expression And Protein Production [Member]
FhCMB [Member]
|
Jun. 30, 2012
LicKM [Member]
FhCMB [Member]
|
Jun. 30, 2011
LicKM [Member]
FhCMB [Member]
|
Jun. 30, 2012
Yellow Fever Vaccine [Member]
Fiocruz [Member]
|
Jun. 30, 2011
Yellow Fever Vaccine [Member]
Fiocruz [Member]
|
Jun. 30, 2012
FhCMB [Member]
|
Jun. 30, 2011
FhCMB [Member]
|
Jun. 30, 2012
Board Of Directors [Member]
|
Jun. 30, 2011
Board Of Directors [Member]
|
Feb. 29, 2012
Chief Scientific Officer [Member]
|
Jun. 30, 2010
Executive Officer [Member]
|
Jun. 30, 2012
Executive Officer [Member]
|
Mar. 01, 2012
Executive Officer [Member]
|
Jun. 30, 2012
Vendor [Member]
|
Jun. 30, 2011
Vendor [Member]
|
|
| Related Party Transaction, Other Revenues from Transactions with Related Party | $ 34,000 | $ 23,000 | ||||||||||||||||||
| Research and Development Arrangement with Federal Government, Description and Terms | The most recent amendment to the TTA requires: a) the Company to make payments to FhCMB of $2,000,000 per year for five years, aggregating $10,000,000, for such services beginning in November 2009; and b) FhCMB to expend at least equal amounts during the same timeframe for research and development services related to the commercialization of the Technology. | The most recent amendment to the TTA requires: 1) the Company to make payments to FhCMB of $2,000,000 per year for five years, aggregating $10,000,000, for such services beginning in November 2009; and 2) FhCMB to expend at least equal amounts during the same timeframe for research and development services related to the commercialization of the Technology. | ||||||||||||||||||
| Related Party Transaction Minimum Annual Payment | 200,000 | |||||||||||||||||||
| Related Party Transaction, Expenses from Transactions with Related Party | 1,000,000 | 643,000 | 457,000 | 296,000 | 135,000 | 1,277,000 | 520,000 | 2,200,000 | 1,533,000 | 85,000 | 1,000 | 225,000 | 0 | |||||||
| Related Party Transaction, Amounts of Transaction | 1,660,000 | 432,000 | 6,500,000 | |||||||||||||||||
| Research and Development Expense | 4,981,040 | 3,083,517 | 6,500,000 | 4,216,000 | 2,445,000 | |||||||||||||||
| Reimbursement Of Patent Related Costs | 177,000 | 223,000 | ||||||||||||||||||
| General and Administrative Expense | 5,623,397 | 7,090,568 | 100,000 | |||||||||||||||||
| Share Based Compensation Arrangement By Share Based Payment Award Value Of Shares Purchased For Award | 15,000 | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award (in Shares) | 60,000 | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased (in Dollars per share) | $ 0.93 | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award Options Vest (in Shares) | 10,000 | |||||||||||||||||||
| Technology Services Costs | 75,000 | |||||||||||||||||||
| Annual Fee Paid To Board Of Director | 10,000 | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) | 2,210,000 | 500,000 | ||||||||||||||||||
| Share Based Compensation Arrangement by Share Based Payment Award Options Vested (in Shares) | 200,000 | |||||||||||||||||||
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in Shares) | 5,510,000 | 4,350,000 | 300,000 | 300,000 | ||||||||||||||||
| Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized | 234,000 | 234,000 | ||||||||||||||||||
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share) | $ 1.80 | $ 2.44 | $ 0.87 | $ 0.87 | ||||||||||||||||
| Accounts Payable, Related Parties, Current | $ 2,524,309 | $ 2,359,794 | $ 64,000 | $ 0 | ||||||||||||||||